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Abstract 
Aims: This study tested whether adolescents who used cannabis or met criteria for cannabis 
dependence showed neuropsychological impairment prior to cannabis initiation and 
neuropsychological decline from before to after cannabis initiation.   
Design: A longitudinal co-twin control study. 
Setting and Participants: Participants were 1,989 twins from the Environmental Risk (E-Risk) 
Longitudinal Twin Study, a nationally representative birth cohort of twins born in 
England and Wales from 1994-1995.  
Measurements: Frequency of cannabis use and cannabis dependence were assessed at age 18. 
Intelligence quotient (IQ) was obtained at ages 5, 12, and 18. Executive functions were assessed 
at age 18. 
Findings:  Adolescents who used cannabis had lower IQ in childhood, prior to cannabis 
initiation, and had lower IQ at age 18, but there was little evidence that cannabis use was 
associated with IQ decline from age 12-18. For example, adolescents with cannabis dependence 
had age-12 and age-18 IQ scores that were 5.61 (t=-3.11, p=.002) and 7.34 IQ points (t=-5.27, 
p<.001) lower than adolescents without cannabis dependence, but adolescents with cannabis 
dependence did not show greater IQ decline from age 12-18 (t=-1.27, p=.20). Moreover, 
adolescents who used cannabis had poorer executive functions at age 18, but these associations 
were generally not apparent within twin pairs. For example, twins who used cannabis more 
frequently than their co-twin performed similarly to their co-twin on 5 of 6 executive function 
tests (ps>.10). The one exception was that twins who used cannabis more frequently than their 
co-twin performed worse on one working memory test (Spatial Span Reversed; β=-0.07, 
p=.036). 
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Conclusions: Family background factors explain why adolescent cannabis users perform worse 
on IQ and executive function tests. Therefore, short-term cannabis use in adolescence does not 
appear to cause IQ decline or impair executive functions, even when cannabis use reaches the 
level of dependence.
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Associations between Adolescent Cannabis Use and Neuropsychological Decline:  
A Longitudinal Co-Twin Control Study 
 Debate concerning cannabis legalization has led to increased urgency to understand the 
effects of cannabis use on health and behavior (1). The effect of cannabis use on 
neuropsychological functions has received considerable research attention, and the general 
consensus is that heavy cannabis use is associated with neuropsychological impairment (2-7). 
However, there is uncertainty regarding the extent to which neuropsychological impairment is 
apparent prior to cannabis use initiation, the age at which cannabis-related neuropsychological 
impairment first emerges, and the level and duration of cannabis exposure that is sufficient to 
produce impairment. One hypothesis is that neuropsychological impairment is apparent in 
childhood, prior to cannabis use initiation. A second hypothesis is that cannabis-induced 
neuropsychological impairment first emerges in adolescence shortly after cannabis use initiation. 
Yet a third hypothesis is that cannabis-induced neuropsychological impairment emerges only 
after years of heavy use. Determining which hypothesis has more support will have critical 
implications for prevention and remediation. 
To address these questions, prospective longitudinal studies are needed. There are only 
nine cohort studies of the association between cannabis use and neuropsychological impairment 
that could inform these questions. These studies included adolescents or young adults in the 
sample and administered neuropsychological tests at two or more time points (Supplemental 
Table 1). Six of these studies assessed neuropsychological functions in childhood, prior to 
cannabis use initiation, and therefore had ‘before and after’ assessments of neuropsychological 
functions (8, 11, 12, 14-17). These six studies found inconsistent evidence for the hypothesis that 
neuropsychological impairment predates cannabis initiation (8, 11, 12, 14-17).  
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Across all nine studies, there was mixed evidence that cannabis use was associated with 
neuropsychological decline (or neuropsychological impairment after accounting for baseline 
neuropsychological functioning). However, studies varied in terms of length of follow-up and the 
cohorts’ level of cannabis exposure. In general, studies with the longest follow-up (8, 9) and 
greatest cannabis exposure (8, 9, 11) tended to show the strongest evidence of cannabis-related 
neuropsychological decline, and studies with the shortest follow-up period and least cannabis 
exposure (14-17) (i.e., studies of adolescent cannabis use) tended to show the weakest evidence. 
This pattern is consistent with the hypothesis that cannabis-induced neuropsychological 
impairment emerges only after years of heavy cannabis use. Nonetheless, firm conclusions 
cannot be drawn for several reasons. First, there are relatively few cohort studies, particularly 
studies that assessed neuropsychological functions prior to cannabis initiation. Second, existing 
cohort studies of adolescents examined low-level cannabis use (14-17), leaving open the 
possibility that neuropsychological impairment might emerge only for adolescents with more 
problematic use. Third, there are many potential confounders of cannabis-neuropsychological 
impairment associations, limiting causal inference.  
The purpose of the present study was to test associations between adolescent cannabis 
use and neuropsychological decline in a cohort of British children followed prospectively from 
age 5-18. Like the few existing cohort studies of adolescent cannabis use (11, 14-17), we 
assessed intelligence (IQ) in childhood, prior to cannabis use initiation. We also assessed IQ and 
executive functions at age 18, after some cohort members had begun using cannabis. Unlike 
other cohort studies of adolescent cannabis use (11, 14-16), we examined cannabis dependence 
as our cannabis exposure, in addition to frequency of cannabis use, as cannabis dependence is an 
indicator of more problematic use. Further, because the cohort comprises twin pairs, it enabled a 
6 
 
comparison of neuropsychological decline for twins in the same family who differed in their 
cannabis use. This within-pair comparison is important because it controls for family background 
factors that might lead to a spurious association between cannabis use and neuropsychological 
decline.  
Methods 
Participants 
Participants were members of the Environmental Risk (E-Risk) Longitudinal Twin Study, 
which tracks the development of a birth cohort of 2,232 British children. The sample was drawn 
from a larger birth register of twins born in England and Wales in 1994–1995 (19). Full details 
about the sample are reported elsewhere (20). Briefly, the E-Risk sample was constructed in 
1999–2000, when 1,116 families (93% of those eligible) with same-sex 5-year-old twins 
participated in home-visit assessments. This sample comprised 56% monozygotic (MZ) and 44% 
dizygotic (DZ) twin pairs; sex was evenly distributed within zygosity (49% male). Families were 
recruited to represent the UK population of families with newborns in the 1990s, on the basis of 
residential location throughout England and Wales and mother’s age. Teenaged women with 
twins were over-selected to replace high-risk families lost to the register through nonresponse. 
Older women having twins via assisted reproduction were under-selected to avoid an excess of 
well-educated older women. These strategies ensured that the study sample represents the full 
range of socioeconomic conditions in Great Britain, as reflected in the families’ distribution on a 
neighborhood-level socioeconomic index (ACORN [A Classification of Residential 
Neighborhoods], developed by CACI Inc. for commercial use) (21, 22): 25.6% of E-Risk 
families live in “wealthy achiever” neighborhoods compared with 25.3% nationwide; 5.3% vs. 
11.6% live in “urban prosperity” neighborhoods; 29.6% vs. 26.9% live in “comfortably off” 
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neighborhoods; 13.4% vs. 13.9% live in “moderate means” neighborhoods; and 26.1% vs. 20.7% 
live in “hard-pressed” neighborhoods. E-Risk underrepresents “Urban Prosperity” because such 
households are significantly more likely to be childless.  
Follow-up home visits were conducted when the children were aged 7 (98% 
participation), 10 (96% participation), 12 (96% participation), and 18 years (93% participation). 
Home visits at ages 5, 7, 10, and 12 included assessments with participants and their mothers; we 
conducted interviews only with participants at age 18 (n=2066). There were no differences 
between those who did and did not take part in the study at age 18 in terms of key measures 
when the cohort was initially defined at age 5: socioeconomic status (χ2=0.86, p=.65), IQ 
(t=0.98, p=.33), or internalizing or externalizing problems (t=0.40, p=.69 and t=0.41, p=.68, 
respectively). Here we report on n=1,989 individuals with IQ data at ages 5, 12, and 18, which 
comprised 96% of all participants seen at age 18. Sample characteristics are shown in Table 1. 
The Joint South London and Maudsley and the Institute of Psychiatry Research Ethics 
Committee approved each phase of the study. Parents gave written informed consent and twins 
gave assent between ages 5-12 and written informed consent at age 18.  
Measures 
Cannabis Use  
Participants were evaluated for past-year cannabis dependence at age 18 according to 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria (23). Four percent 
(n=84) of participants were diagnosed with cannabis dependence. Of the 977 complete twin 
pairs, most were concordant for not having cannabis dependence (n=908 pairs). Twelve pairs 
were concordant for dependence and 57 pairs were discordant for cannabis dependence. 
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Participants reported on how often they used cannabis in the past year at age 18. 
Responses were: ‘0’=never (63%), ‘1’=less than monthly (28%), ‘2’=monthly (3%), ‘3’=weekly 
(3%), ‘4’=daily (2%), and ‘5’=many times a day (1%). The correlation between twins within a 
pair on frequency of use was r=0.55 (p<.001). 
Intelligence Quotient (IQ) 
Intelligence was assessed at ages 5 and 12, before cannabis initiation, and again at age 18. 
(Only 19 participants had tried cannabis at age 12.) At age 5, we used a short form of the 
Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R) (24). Using two 
subtests (Vocabulary and Block Design), we pro-rated children’s age-5 IQ following procedures 
described by Sattler (25). At age 12, we used the Wechsler Intelligence Scale for Children-
Revised (WISC-R) (26). At age 18, we used the Wechsler Adult Intelligence Scale–IV (WAIS-
IV) (27). At ages 12 and 18, two of the same subtests were administered -- Information and 
Matrix Reasoning. These two subtests were used to obtain pro-rated full-scale IQ at ages 12 and 
18. Pro-rated full-scale IQ scores were standardized on the full sample at each age to M=100, 
SD=15, and subtest scores were standardized to M=10, SD=3. 
Executive Functions 
At age 18, executive functions tapping attention/vigilance and working memory were 
assessed with tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB) 
(28). The CANTAB is a computerized test battery of neuropsychological functioning that uses 
touch-screen technology. Tests are described in Supplemental Table 2. Scores on each 
executive function test were standardized to M=0, SD=1.  
Statistical Analyses 
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We used linear regression to test whether age-18 cannabis use was associated with (a) 
lower IQ at ages 5, 12, and 18, (b) IQ decline from age 12-18 (with IQ decline represented as a 
change score: age-18 IQ minus age-12 IQ), and (c) poorer executive functioning at age 18. We 
focused on IQ decline from age 12-18 (and not age 5-18) because the age-12 and age-18 IQ 
scores were based on the same two subtests (Information and Matrix Reasoning) whereas the 
age-5 IQ scores were based on different subtests. However, age-5 IQ was included as a covariate 
in analyses of IQ decline. For tests of associations between cannabis use and executive 
functioning at age 18, we included age-12 IQ as a covariate. Sex was included as a covariate in 
all analyses, as, relative to girls, boys had higher rates of cannabis use and dependence, had 
slightly higher IQ at ages 12 and 18, and showed a greater increase in IQ from age 12-18 (Table 
1). However, there was little evidence that associations between cannabis use and 
neuropsychological functioning differed for boys and girls.   
We conducted analyses in the full sample of twins, which approximates the general 
population, and adjusted for the non-independence of observations (twins nested within twin 
pairs) by using the SURVEYREG procedure in SAS. The SURVEYREG procedure uses Taylor 
linearization to estimate sampling errors of estimators. We also conducted co-twin control 
analyses comparing twins within the same family who differed in their level of cannabis use. Co-
twin control analyses allow us to come closer to causal inference because they inherently control 
for a variety of unmeasured family background factors. The logic is as follows. In the full sample 
of twins, differences between cannabis dependent and non-dependent adolescents, for example in 
terms of SES, neighborhood, or educational opportunities, could lead to a spurious association 
between cannabis dependence and lower IQ. In contrast, twins from the same family share 
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family backgrounds, and therefore, these family factors cannot explain IQ differences between 
twins discordant for dependence.  
Co-twin control analyses differed slightly depending on the cannabis exposure. For 
cannabis dependence, analyses were conducted as described above for the full sample, but the 
sample was limited to the 57 twin pairs discordant for dependence. For frequency of cannabis 
use, we used all complete twin pairs (n=977) and computed twin difference scores for frequency 
of use (e.g., twin-1 frequency minus twin-2 frequency) and outcomes (IQ at ages 5, 12, and 18; 
IQ decline from 12-18; and age-18 executive functions). Then, we regressed twin differences in 
outcomes on twin differences in frequency of use. Findings from co-twin control analyses are 
reported for the combined sample of DZ and MZ twins to avoid loss of power resulting from 
reporting on them separately. There was little evidence that associations differed by zygosity. 
Results 
Associations between Cannabis Dependence and IQ  
Table 2 shows mean pro-rated IQ scores for cannabis-dependent and non-dependent 
adolescents in the full sample and in the subsample of discordant twin pairs. First, we review 
findings for the full sample. Adolescents with cannabis dependence at age 18 had lower IQ at 
ages 5, 12, and 18 (95.18, 94.95, and 93.14, respectively) compared with non-dependent 
adolescents (100.48, 100.56, and 100.48, respectively), but there was only weak evidence that 
adolescents with cannabis dependence showed greater IQ decline from age 12-18 (-1.81 IQ 
points) than non-dependent adolescents (-0.08 IQ points) (t=-1.27, p=.20) (Table 2). Findings 
were similar after controlling for age-5 IQ.  
 Results for discordant twin pairs differed from results for the full sample in that twins 
with cannabis dependence performed similarly to their co-twins without cannabis dependence on 
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the IQ tests at each age (Table 2). For example, cannabis-dependent twins had an age-5 IQ of 
94.26, and their non-dependent co-twins had an age-5 IQ of 93.50 (Table 2). Thus, the average 
age-5 IQ difference between discordant twins was only 0.76 IQ points. (This same result is 
obtained by subtracting twin-1 IQ from twin-2 IQ within a discordant pair and averaging that 
difference across twins.) Therefore, unlike in the full sample, there was no evidence from 
discordant pairs that cannabis-dependent adolescents had lower IQ at any age, suggesting that 
family background factors explain why, in the full sample, cannabis-dependent adolescents had 
lower IQ. That family factors confounded the cannabis-IQ association is also apparent in the 
means for discordant twin pairs, which show that both the cannabis-dependent and non-
dependent twins from discordant pairs had lower IQ relative to the full sample. That is, non-
dependent adolescents from families in which a sibling had dependence had lower IQ relative to 
norms (mean IQ=100). 
Findings for the full sample and the subsample of discordant twins were similar after 
excluding 19 participants who had used cannabis at age 12 (Supplemental Table 3). Results for 
the Information and Matrix Reasoning subtests were similar to results for full-scale IQ 
(Supplemental Tables 4-5).  
Associations between Frequency of Cannabis Use and IQ  
Because only 4% of twins were cannabis dependent but 37% of them had used cannabis, 
we repeated all analyses based on frequency of cannabis use. This allowed for greater variation 
and power to detect differences. In the full sample, more frequent cannabis use at age 18 was 
associated with lower IQ at ages 12 and 18 (but not age 5) and greater IQ decline from age 12-
18, but the effect was small (Table 3). For every standard deviation increase in frequency of 
cannabis use, IQ declined by an additional 0.05 standard deviations. Associations were similar 
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after controlling for age-5 IQ. Among twin pairs, we found that the more frequently cannabis-
using twin did not show lower IQ at any age or greater IQ decline than their co-twin (Table 3).  
We conducted sensitivity analyses comparing IQ for adolescents who did not use 
cannabis at age 18 with adolescents who used cannabis at least weekly, under the hypothesis that 
relatively trivial differences between adolescents in frequency of use obscure effects at the 
extremes of use. However, there was little evidence that weekly cannabis users showed greater 
IQ decline than non-users (Supplemental Table 6).  
Associations between Cannabis Dependence and Executive Functions  
Table 4 shows mean executive function scores at age 18 for cannabis-dependent and 
non-dependent adolescents in the full sample and in the subsample of discordant twins. In the 
full sample, cannabis-dependent adolescents performed worse on 4 of 6 tests (RVP A Prime, 
SWM Strategy, Spatial Span Forward, and Spatial Span Reversed). After controlling for age-12 
IQ, cannabis-dependent adolescents performed worse on only 2 of 6 tests (Spatial Span Forward 
and Reversed). However, no differences were apparent among discordant twins. 
Associations between Frequency of Cannabis Use and Executive Functions  
 In the full sample, more frequent cannabis use at age 18 was associated with worse 
performance on all executive function tests except one, even after controlling for age-12 IQ 
(Table 5). However, most of these associations were not apparent within twin pairs – i.e., when 
we compared each twin to their co-twin. (Table 5). The only exception was that twins who used 
cannabis more frequently than their co-twin performed worse on the Spatial Span Reversed task, 
but the effect was small (β=-0.07, p=.022). 
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We conducted sensitivity analyses comparing adolescents who had not used cannabis in 
the past year with adolescents who had used cannabis at least weekly in the past year 
(Supplemental Table 7). Findings were similar.  
Discussion 
In a cohort of British youth followed from age 5-18, we found that youth who used 
cannabis at age 18 had lower IQ in childhood, prior to cannabis initiation, and had lower IQ at 
age 18, but there was little evidence that cannabis use was associated with IQ decline from age 
12-18. Moreover, although cannabis use was associated with lower IQ and poorer executive 
functions at age 18, these associations were generally not apparent within pairs of twins from the 
same family, suggesting that family background factors explain why adolescents who use 
cannabis perform worse on IQ and executive function tests. Results were similar regardless of 
how we defined cannabis exposure – i.e., in terms of frequency of use or the more problematic 
outcome of dependence. Findings suggest that cannabis use does not cause IQ decline or impair 
executive functions in adolescence after relatively short-term use, even when use reaches the 
level of dependence. 
Our finding that lower IQ predates cannabis use contributes to already mixed findings in 
this area. Of the six cohort studies that obtained neuropsychological data prior to cannabis use 
initiation, four found no evidence that lower IQ predated cannabis use (8, 12, 15, 17), and two 
found at least some evidence that lower IQ or poorer executive functions predated cannabis use 
(14, 16) (Supplemental Table 1). The reasons for this discrepancy are unclear. One potential 
explanation is that birth-cohort differences in structural factors (e.g., cannabis price, ease of 
access to cannabis) explain between-study differences in adolescent characteristics (e.g., 
socioeconomic status, IQ) associated with cannabis use. 
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We found that adolescents with cannabis dependence showed similar changes in IQ from 
age 12-18 to adolescents without cannabis dependence. This lack of an association between 
cannabis dependence and IQ decline was apparent in the full sample of twins, a sample that 
approximates the general population, and in the subsample of twins discordant for cannabis 
dependence. Results were generally similar when we considered frequency of cannabis use as 
our exposure, with one exception. There was some evidence that more frequent cannabis use 
(considered on a continuum from no use to many uses per day) was associated with IQ decline in 
the full sample, but the effect size was small. Further, this association was not apparent within 
twin pairs in an analysis that inherently controlled for family background factors. Overall, there 
was limited evidence that cannabis use was associated with IQ decline during adolescence.  
Our finding that adolescent cannabis use was not associated with IQ decline is broadly 
consistent with findings from several recent cohort studies (14-17), one of which used a co-twin 
control design (14), similar to the current study. Our study builds on these previous studies by 
showing no effect of a more problematic level of cannabis use -- cannabis dependence. Notably, 
accumulating findings of no association between cannabis use and IQ decline in adolescence do 
not conflict with our previous report from the Dunedin Study that persistent cannabis use is 
associated with IQ decline. In that study, adolescents who met criteria for cannabis dependence 
persistently through adulthood showed an 8-point IQ decline from age 18-38, whereas 
adolescents who met criteria for cannabis dependence only at age 18 (and not thereafter) did not 
show IQ decline (8), similar to what we report here. 
In the current study, adolescent cannabis use was associated with impaired executive 
functions, including impaired attention/vigilance and spatial working memory, in the full sample 
but not in the subsample of twin pairs. For example, twins with cannabis dependence performed 
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no worse on executive function tests than their co-twins without cannabis dependence, 
suggesting that family background factors contribute to a spurious association between cannabis 
dependence and impaired executive functions in the general population. However, when we used 
frequency of cannabis use as our exposure, we found that more frequently cannabis using twins 
performed slightly worse on the Spatial Span Reversed test than their co-twins who used 
cannabis less frequently, suggesting a possible causal association between cannabis use and 
impairment on this one test. However, this finding might have been a false positive, particularly 
given previous inconsistent findings of an association between cannabis use and working 
memory (5).  
 This study has limitations. First, cannabis use was based on self-reports. Although this is 
typical for cohort studies, biological tests could have helped to detect under-reporting. Second, 
although we tested associations between cannabis use and multiple executive function tests, we 
lacked tests of other neuropsychological functions, such as memory, which has been shown to be 
impaired in adolescent cannabis users (7, 29). Third, due to small sample sizes, discordant twin 
analyses may have been underpowered to detect effects. We note, however, that effect sizes were 
close to zero in many analyses. Fourth, although we were able to examine cannabis dependence, 
a level of problem use that has not been studied in previous cohorts of adolescents, it is possible 
that cannabis-related neuropsychological impairment only becomes apparent after more intense 
cannabis use (e.g., multiple uses per day), which was rare in our cohort at 1% prevalence. Very 
large cohort studies, like the Adolescent Brain Cognitive Development study of 10,000 9-10 
years followed for 10 years (30), are needed to obtain a sufficient number of adolescents from 
the general population who use cannabis intensely.  
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This study has a number of implications. First, to accurately interpret associations 
between cannabis use and neuropsychological impairment, it is important to test 
neuropsychological functions before cannabis initiation. Second, relatively short-term cannabis 
use in adolescence does not appear to cause IQ decline or impair executive functions, even when 
cannabis use reaches the level of dependence. Third, more research is needed to test the 
possibility that cannabis-related neuropsychological impairment develops gradually over time 
such that obvious impairment is only apparent in older, longer-term persistent users.  
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Table 1. Sample characteristics. 
 Full Sample 
(N=1989) 
Girls  
(N=1049) 
Boys  
(N=940) Test of Sex Difference 
Characteristic M (SD) M (SD) M (SD) β/OR p 
Sex (% Male) 47.26 - - - - 
Zygosity (% Dizygotic) 43.99 42.70 45.42 OR=1.12a .39 
SES 2.00 (0.82) 2.01 (0.82) 1.99 (0.81) -0.01 .79 
Age 5 IQ 100.19 (15.00) 100.21 (14.37) 100.17 (15.69) 0.00 .97 
Age 12 IQ 100.33 (14.75) 99.31 (13.64) 101.47 (15.83) 0.07 .012 
Age 18 IQ 100.17 (14.88) 98.27 (13.95) 102.30 (15.59) 0.14 <.001 
Cannabis Use (% Used in Past Year) 37.56 30.03 45.96 OR=1.98a <.001 
Cannabis Dependence (%) 4.22 2.57 6.06 OR=2.44a <.001 
Note. SES=socioeconomic status. SES was assessed on a three-point scale with 1=low SES and 3=high SES. a. These analyses used 
logistic regression to test whether boys had greater odds of being a dizygotic (versus monozygotic) twin than girls; greater odds of 
past-year cannabis use; and greater odds of cannabis dependence than girls. All other analyses used linear regression (i.e., to test 
whether boys had higher SES and higher IQ than girls), and standardized beta coefficients are reported.  
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Table 2. Mean pro-rated IQ scores at ages 5, 12, and 18 and average within-person IQ change from age 12 to 18 as a function of cannabis dependence at 
age 18.  
         
         
Full sample 
Non-
Dependent 
Adolescents 
(N=1905) 
Cannabis 
Dependent 
Adolescents 
(N=84) 
Difference Between 
Non-Dependent and 
Cannabis Dependent 
Adolescentsa t p 
Difference Between 
Non-Dependent and 
Cannabis Dependent 
Adolescents After 
Controlling for Age 5 
IQa t p 
Age 5 IQ 100.41 95.18 -5.23 -2.94 .003 - - - 
Age 12 IQ 100.56 94.95 -5.61 -3.11 .002 -2.80 -1.78 .08 
Age 18 IQ 100.48 93.14 -7.34 -5.27 <.001 -4.82 -3.88 <.001 
IQ Change From Age 12-18b -0.08 -1.81 -1.73 -1.27 .20 -2.02 -1.49 .14 
         
Discordant Twins 
Non-
Dependent 
Twins 
(N=57) 
Cannabis 
Dependent 
Co-Twin 
(N=57) 
Difference Between 
Discordant Twin 
Pairsa t p 
Difference Between 
Discordant Twin Pairs 
After Controlling for 
Age 5 IQa t p 
Age 5 IQ 93.50 94.26 0.76 0.39 .70 - - - 
Age 12 IQ 95.47 93.97 -1.50 -0.80 .43 -1.81 -0.94 .35 
Age 18 IQ 94.31 92.86 -1.45 -0.81 .42 -1.77 -0.97 .33 
IQ Change From Age 12-18b -1.16 -1.11 0.05 0.02 .98 0.04 0.02 .99 
Note.  Means and statistical tests are adjusted for sex. a. Negative scores indicate that adolescents with cannabis dependence showed lower IQ/greater IQ 
decline than non-dependent adolescents. For example, results for the full sample show that IQ decline for adolescents with cannabis dependence was 1.73 
points greater than IQ decline for adolescents without cannabis dependence. b. IQ change was represented as a change score (age 18 IQ – age 12 IQ). We 
focused on IQ decline from age 12 to 18 because the age 12 and age 18 pro-rated IQ scores were based on the same two subtests (Information and Matrix 
Reasoning) whereas the age 5 pro-rated IQ scores were based on different subtests (Vocabulary and Block Design). Results are shown with and without 
adjustment for age 5 IQ. Statistically significant differences are shown in bold.  
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Table 3. Associations between frequency of cannabis use at age 18 and (a) pro-rated IQ at ages 5, 12, 
and 18, and (b) IQ decline from age 12 to 18. 
     
 Before Controlling for Age 5 IQ After Controlling for Age 5 IQ 
Full Sample (n=1,989) βa p βa p 
Age 5 IQ -0.05 .07 - - 
Age 12 IQ -0.11 <.001 -0.08 <.001 
Age 18 IQ -0.15 <.001 -0.12 <.001 
IQ Change from Age 12-18c -0.05 .035 -0.05  .023 
     
Twin Pairs (n=977 twin pairs) βb p βb p 
Age 5 IQ 0.02 .56 - - 
Age 12 IQ 0.03 .32 0.03 .37 
Age 18 IQ 0.00 .94 0.00 .97 
IQ Change from Age 12-18c -0.02 .46 -0.02 .47 
Note. Estimates are standardized regression coefficients. All associations are adjusted for sex. a. 
Negative estimates indicate that more frequent cannabis use at age 18 was associated lower IQ/greater 
IQ decline from age 12 to 18. b. Positive estimates indicate that the twin who used cannabis more 
frequently at age 18 showed higher IQ/less IQ decline than their co-twin. c. IQ change was represented 
as a change score (age 18 IQ – age 12 IQ). We focused on IQ decline from age 12 to 18 because the 
age 12 and age 18 pro-rated IQ scores were based on the same two subtests (Information and Matrix 
Reasoning) whereas the age 5 pro-rated IQ scores were based on different subtests (Vocabulary and 
Block Design). Results are shown with and without adjustment for age 5 IQ. Statistically significant 
differences are shown in bold. 
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Table 4.  Mean executive function scores at age 18 as a function of cannabis dependence at age 18.  
                 
 Full Sample Discordant Twins  
 Before Controlling for  
Age 12 IQ 
After Controlling for  
Age 12 IQ 
Before Controlling for  
Age 12 IQ 
After Controlling for  
Age 12 IQ 
Executive 
Function Test 
Not 
Dep 
(N= 
1,902) 
Dep 
(N=
84) t p 
Not 
Dep 
(N= 
1,902) 
Dep 
(N=
84) t P 
Not 
Dep 
(N= 
57) 
Dep 
(N= 
57) t p 
Not 
Dep 
(N= 
57) 
Dep 
(N= 
57) t p 
RVP A Prime 0.02 -0.22 -2.26 .024 0.01 -0.07 -0.85 .39 -0.12 -0.21 -0.65 .52 -0.13 -0.20 -0.49 .62 
                 
RVP Total False 
Alarmsa 0.00 0.02 0.21 .83 0.00 -0.06 -0.57 .57 0.30 0.07 -1.11 .27 0.32 0.06 -1.23 .22 
                 
SWM Total 
Errorsa -0.01 0.18 1.80 .07 -0.01 0.04 0.54 .59 0.25 0.15 -0.69 .49 0.27 0.13 -0.97 .34 
                 
SWM Strategya -0.01 0.21 2.40 .017 0.00 0.08 1.00 .32 0.24 0.19 -0.36 .72 0.26 0.17 -0.62 .54 
                 
Spatial Span 
Forward 0.02 -0.48 -4.57 <.001 0.01 -0.35 -3.60 <.001 -0.18 -0.38 -1.30 .20 -0.19 -0.37 -1.15 .26 
                 
Spatial Span 
Reversed 0.01 -0.33 -3.37 <.001 0.01 -0.20 -2.17 .030 -0.16 -0.26 -0.75 .46 -0.17 -0.25 -0.59 .56 
Note.  Means and statistical tests are adjusted for sex. a. Higher scores are worse. Not dep=not cannabis dependent. Dep=cannabis dependent. 
RVP=Rapid Visual Processing. SWM=Spatial Working Memory. For the full sample, Ns ranged from 1895 to 1902 for the non-dependent group and 
83-84 for the dependent group, as a few people from each group did not complete all executive function tests. For discordant twins, Ns ranged from 
56 to 57 twin pairs. Statistically significant differences are shown in bold. 
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Table 5. Associations between frequency of cannabis use at age 18 and performance on executive function tests at age 18. 
         
 Full Sample (n=1985) Twin Pairs (n=974 pairs) 
 Before Controlling for 
Age 12 IQ 
After Controlling for 
Age 12 IQ 
Before Controlling for 
Age 12 IQ 
After Controlling for Age 
12 IQ 
Executive Function Test β p β p β p β p 
RVP A Prime -0.10 <.001 -0.05 .020 0.00 .96 -0.01 .76 
         
RVP Total False Alarmsa 0.04 .08 0.01 .56 -0.01 .77 -0.01 .84 
         
SWM Total Errorsa 0.10 <.001 0.06 .005 0.03 .40 0.03 .29 
         
SWM Strategya 0.10 <.001 .06 <.001 0.01 .87 0.01 .75 
         
Spatial Span Forward -0.13 <.001 -0.09 <.001 -0.04 .22 -0.05 .14 
         
Spatial Span Reversed -0.13 <.001 -0.09 <.001 -0.07 .036 -0.07 .022 
Note. Ns for the full sample ranged from 1978-1985. Ns for twin pairs ranged from  967-974 twin pairs. Ns varied slightly as not all 
adolescents completed each executive function test. Estimates are standardized beta coefficients, adjusted for sex. RVP=Rapid Visual 
Processing. SWM=Spatial Working Memory.  a. Higher scores are worse, so on these tests, positive coefficients for the full sample 
indicate that more frequent cannabis use was associated with worse performance on executive functions tests, and positive coefficients 
for twin pairs indicate that the twin who used cannabis more frequently performed worse on the executive function test than their co-
twin. For all other tests, lower scores are worse, so negative coefficients indicate that more frequent cannabis use was associated with 
worse test performance. Statistically significant associations are shown in bold. 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
          
Meier et 
al. 2012 
(8) 
874 25 y 7-13 38 28% never 
used cannabis; 
58% used 
cannabis but 
never 
regularly (at 
least 4 days 
per week); 5% 
used regularly 
at one point in 
their lives; 9% 
were 
persistent 
regular users 
(used 
regularly at 
two or more 
points in their 
lives). Of 
those who had 
used cannabis, 
55% never 
diagnosed 
with cannabis 
dependence; 
9% diagnosed 
at one point in 
their lives; and 
8% diagnosed 
Partially IQ, executive 
functions, memory, 
processing speed, 
perceptual 
reasoning, verbal 
comprehension 
There was no evidence 
that neuropsychological 
impairment was 
apparent prior to 
cannabis use initiation.  
Persistent cannabis use from 
age 18-38 was associated with 
IQ decline from age 7-13 to age 
38, even after accounting for a 
variety of covariates. Persistent 
cannabis use from age 18-38 
was also associated with poorer 
executive functions, memory, 
processing speed, perceptual 
reasoning, and verbal 
comprehension at age 38, even 
after accounting for age 7-13 
IQ. 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
with cannabis 
dependence 
persistently.  
          
Auer et 
al. 2016 
(9) 
3,385 25 y 18-30 43-55 16% never 
used cannabis; 
44% had used 
cannabis daily 
for <0.5 years; 
24% had used 
cannabis daily 
for 0.5-2 
years; 7% had 
used cannabis 
daily for 2-5 
years; 9% had 
used cannabis 
daily for >5 
years. 
No Verbal memory, 
processing speed, 
executive functions 
This study could not 
test whether 
neuropsychological 
impairment was 
apparent prior to 
cannabis use, as 
participants had already 
initiated cannabis use at 
the time of the first 
neuropsychological 
assessment.  
Cumulative lifetime cannabis 
use was associated with worse 
verbal memory, processing 
speed, and executive function in 
adulthood. After accounting for 
earlier cognitive functioning 
and a variety of covariates, 
cumulative cannabis use was 
associated with worse verbal 
memory in adulthood. 
          
Lyketsos 
et al. 
1999 (10) 
1,318 12 y 18-64 30-76 61% had 
never used 
cannabis (non-
users); 28% 
had used 
cannabis but 
never used it 
daily or more 
often for over 
2 weeks (light 
Yes Mini-Mental Status 
Exam 
This study could not 
test whether 
neuropsychological 
impairment was 
apparent prior to 
cannabis use, as 
participants had already 
initiated cannabis use at 
the time of the first 
Light and heavy cannabis users 
did not show greater decline on 
the mini-mental status exam 
than non-users. 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
users); 11% 
had used 
cannabis daily 
or more often 
for over 2 
weeks (heavy 
users). 
neuropsychological 
assessment.  
          
          
Fried et 
al. 2005 
(11) 
113 ~8 y 9-12 17-21 52% of the 
sample had 
never used 
cannabis; 17% 
of the sample 
were current 
light users (<5 
joints per 
week) and had 
consumed a 
total of 
M=122 joints; 
17% of the 
sample were 
current heavy 
users (>5 
joints per 
week) and had 
consumed a 
total of 
M=1884 
Partially IQ, processing 
speed, vocabulary, 
immediate and 
delayed memory, 
working memory, 
sustained attention, 
abstract reasoning 
This study did not 
report on whether 
neuropsychological 
impairment was 
apparent prior to 
cannabis use initiation, 
although a prior report 
based on this cohort 
found no evidence that 
cannabis users had 
lower IQ prior to 
cannabis use initiation 
(12).  
Current heavy cannabis users 
performed worse than non-users 
on IQ, processing speed, and 
immediate and delayed memory 
in young adulthood, even after 
accounting for pre-drug 
performance on the relevant 
cognitive test and a variety of 
covariates. Current light users 
and former cannabis users did 
not perform worse than non-
users on any test. 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
joints; and 
14% were 
former users 
(no regular 
use for 3+ 
months and <3 
joints in the 
past 2 months 
at the age 17-
21 
assessment) 
and had 
consumed a 
total of 
M=2203 
joints.  
          
Tait et al. 
2011 (13) 
1,499 8 y 20-24 28-32 28% of the 
sample had 
never used; 
44% were 
classified as 
always former 
users (had 
used cannabis 
prior to 
baseline but 
not thereafter); 
15% were 
classified as 
Yes Immediate and 
delayed recall, short-
term memory, verbal 
ability, processing 
speed 
This study could not 
test whether 
neuropsychological 
impairment was 
apparent prior to 
cannabis use, as 
participants had already 
initiated cannabis use at 
the time of the first 
neuropsychological 
assessment.  
Analyses compared change in 
neuropsychological functions 
for the following groups: former 
heavy cannabis users vs. remain 
heavy cannabis users; former 
light users vs. remain light 
users; never users vs. former 
heavy users; never users vs. 
former light users; and never 
users versus always former 
users. After adjustment for 
covariates, the only statistically 
significant findings were as 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
former light 
(monthly or 
less) users 
(light use prior 
to the last 
wave of data 
collection and 
no use at the 
last wave); 4% 
were classified 
as former 
heavy (at least 
weekly) users; 
5% were 
classified as 
remain light 
users; and 4% 
were classified 
as remain 
heavy users. 
follows: Former heavy cannabis 
users showed improvement in 
immediate recall relative to 
heavy users.  
          
Jackson 
et al. 
2016 (14) 
Sample 
1: 789; 
Sample 
2: 2,277 
10 y; 
~7 y 
Sample 1: 
9-10; 
Sample 2: 
11-12 
Sample 
1:  
19-20; 
Sample 
2:  
17-19 
Sample 1: 
60% of the 
sample had 
used cannabis; 
30% had used 
cannabis 30+ 
times; 12.5% 
had used 
cannabis daily 
Yes IQ There was mixed 
evidence that cannabis 
users had lower IQ 
prior to cannabis use 
initiation.  
Cannabis use (defined as ever 
use) was associated with decline 
in Vocabulary and Information 
subtests, even after accounting 
for a variety of 
sociodemographic covariates. 
Associations were no longer 
apparent in sample 2 after 
accounting for other substance 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
for 6-12 
months; 
Sample 2: 
36% of the 
sample had 
used cannabis; 
13% had used 
cannabis 30+ 
times; 8% had 
used cannabis 
daily for 6-12 
months. 
use. There was no evidence that 
cannabis use was associated 
with decline in Similarities, 
Block Design, Matrix 
Reasoning, and Picture 
Arrangement subtests. Use of 
cannabis 30+ times and daily 
cannabis use for 6-12 months 
were also not associated with 
IQ decline among users. 
Moreover, among twins 
discordant for cannabis use, 
cannabis use was not associated 
with IQ decline on any subtest. 
          
Mokrysz 
et al. 
2016 (15) 
2,235 7 y 8 15 77% had 
never used 
cannabis; 11% 
had used 
cannabis <5 
times; 6% had 
used cannabis 
5-19 times; 
3% has used 
cannabis 20-
49 times; 3% 
had used 
cannabis 50+ 
times. 
No IQ There was no evidence 
that cannabis users had 
lower IQ prior to 
cannabis use initiation.  
Cumulative cannabis use by age 
15 was associated with lower 
IQ at age 15, after controlling 
for age 8 IQ. This association 
was no longer apparent after 
controlling for covariates. 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
Castellan
os-Ryan 
et al. 
2016 (16) 
294 7 y 13 20 Average 
cannabis use 
ranged from 
no use in the 
past year at 
age 14 to 
between 3-5 
and 6-9 uses 
in the past 
year at age 17. 
Partially Verbal IQ, short-
term memory, 
executive functions 
Higher verbal IQ at age 
13 was associated with 
an earlier age of onset 
of cannabis use and 
greater increases in 
frequency of cannabis 
use from ages 14-17. 
Poorer short-term 
memory and working 
memory at age 14 were 
associated with an 
earlier age of onset of 
cannabis use.  
Greater frequency of cannabis 
use at age 14 was associated 
with decline in one of several 
tests of executive functions, 
even after controlling for a 
variety of covariates. Greater 
increases in cannabis use from 
age 14-17 were associated with 
decline in verbal IQ and one of 
several tests of executive 
functions, with the association 
with verbal IQ becoming non-
significant after controlling for 
covariates. 
          
Boccio & 
Beaver, 
2017 (17) 
Varied 
from 
373 to 
6,584 
6 y 12-21 
(Wave I) 
18-26 
(Wave 
III) 
No 
participants 
had used 
cannabis at 
Wave I. 12% 
had used 
cannabis in 
the past year 
at Wave II and 
70% had used 
cannabis in 
the past year 
at Wave III. 
Among 
cannabis 
Yes Verbal IQ There was no evidence 
that cannabis users had 
lower IQ prior to 
initiation.  
Dichotomous measures of 
cannabis use (e.g. past-year 
cannabis use vs. no use) at 
Waves II and III were each 
associated with verbal IQ 
decline from Waves I-III. 
However, number of cannabis 
use days in the past month at 
Waves II and III were not 
associated with verbal IQ 
decline from Waves I-III. There 
was also inconsistent evidence 
of cannabis-related verbal IQ 
decline based on cannabis use 
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Supplemental Table 1. Cohort studies of associations between cannabis use and neuropsychological functioning. Studies are organized by length of follow-up and date. 
Study 
Sample 
Size 
Length 
of 
Follow-
Up 
Baseline 
Age or 
Age 
Range 
Follow
-Up 
Age or 
Age 
Range 
Level of 
Cannabis 
Exposure 
Same 
Tests 
Across 
Time? 
Neuropsychological  
Domains 
Findings: 
Neuropsychological 
Differences Before 
Cannabis Initiation 
Findings: Cannabis-Related 
Change in Neuropsychological 
Function  
users, the 
average 
number of 
days of 
cannabis use 
in the past-
month at 
Waves II and 
III was 3 and 
7 days, 
respectively. 
data combined across Waves II 
and III. 
Note. This table includes only those cohort studies with (a) adolescents or young-adults in the sample, (b) neuropsychological testing at two or more time points, and (c) 
follow-up of at least 1 year. There was one longitudinal case-control study of adolescents with and without a diagnosis of substance use disorder, and it found that 
cumulative cannabis use from ~ age 16 to 24 was associated with poorer attention in young adulthood, even after controlling for baseline attention and other covariates. 
However, cannabis use was not associated with poorer neuropsychological function in other domains (language, visuospatial abilities, verbal learning and memory, and 
executive functions) (18). 
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Supplemental Table 2. Description of executive function measures from the Cambridge Neuropsychological Test Automated Battery 
(CANTAB). 
  
Test Description 
Rapid Visual Information Processing (RVP) This is a test of sustained attention and vigilance. A white box appears in the 
center of the computer screen, inside which digits from 2 to 9 appear in a 
pseudo-random order at the rate of 100 digits per minute. Subjects are 
requested to detect target sequences of digits (for example, 2-4-6, 3-5-7, 4-6-
8) and to register responses using the press pad. At the most difficult level, 
the participant scans simultaneously for two target sequences. 
  
RVP A-prime This is a signal detection measure of sensitivity to the target, regardless of 
response tendency (range 0.00 to 1.00; bad to good) and is a measure of how 
good the subject is at detecting target sequences using "Probability of Hit" 
and "Probability of False Alarm." Higher scores are better. 
  
RVP Total False Alarms This measure records impulsive jumping to respond too soon before the 
correct target digit sequence is complete. Because relatively few participants 
made numerous false alarms, this measure is categorical, coded 0=none, 1=1 
false alarm, 2=2 or more false alarms. Higher scores are worse. 
  
Spatial Working Memory Test The test begins with a number of colored squares (boxes) being shown on the 
screen. The aim of this test is that, by touching the boxes and using a process 
of elimination, the participant should find one blue ‘token’ in each of a 
number of boxes and use them to fill up an empty column on the right hand 
side of the screen. The number of boxes is gradually increased, until it is 
necessary to search a total of eight boxes. The color and position of the boxes 
used are changed from trial to trial to discourage the use of stereotyped search 
strategies.  
  
Spatial Working Memory Total Errors This measures assesses capacity to hold information about spatial location in 
active memory while searching for information. At the most difficult level, 
participants memorize 10 locations in one problem. Higher scores are worse. 
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Spatial Working Memory Strategy This measure records trials on which the participant applied a problem-
solving strategy by opening boxes in a systematic sequence. Higher scores are 
worse (more non-strategic trials). 
 
 
Spatial Span This measure is the visual non-verbal equivalent of the oral-auditory Digit 
Span test and measures working memory. At the most difficult level, 
participants memorize a sequence of 9 colored stimuli.  
  
Spatial Span Forward This measure is the visual non-verbal equivalent of the oral-auditory Digit 
Span forward test. Higher scores are better. 
  
Spatial Span Reversed This measure is the visual non-verbal equivalent of the oral-auditory Digit 
Span backward test. Higher scores are better. 
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Supplemental Table 3. Mean pro-rated IQ scores at ages 5, 12, and 18 and average within-person IQ change from age 12 to 18 as a function of cannabis 
dependence at age 18. These analyses exclude the 19 participants who had used cannabis at age 12. 
         
         
Full sample 
Non-
Dependent 
Adolescents 
(N=1889) 
Cannabis 
Dependent 
Adolescents 
(N=81) 
Difference Between 
Non-Dependent and 
Cannabis Dependent 
Adolescentsa t p 
Difference Between 
Non-Dependent and 
Cannabis Dependent 
Adolescents After 
Controlling for Age 5 
IQa t p 
Age 5 IQ 100.40 95.25 -5.15 -2.80 .005 - - - 
Age 12 IQ 100.61 95.20 -5.41 -2.94 .003 -2.66 -1.66 .10 
Age 18 IQ 100.53 93.57 -6.96 -4.95 <.001 -4.86 -3.58 <.001 
IQ Change From Age 12-18b -0.08 -1.63 -1.55 -1.11 .27 -1.83 -1.31 .19 
         
Discordant Twins 
Non-
Dependent 
Twins 
(N=54) 
Cannabis 
Dependent 
Co-Twin 
(N=54) 
Difference Between 
Discordant Twin 
Pairsa t p 
Difference Between 
Discordant Twin Pairs 
After Controlling for 
Age 5 IQa t p 
Age 5 IQ 93.76 94.28 0.52 0.25 .80 - - - 
Age 12 IQ 95.26 94.24 -1.02 -0.55 .58 -1.23 -0.64 .52 
Age 18 IQ 94.58 93.39 -1.19 -0.64 .52 -1.40 -0.79 .45 
IQ Change From Age 12-18b -0.68 -0.85 -0.17 -0.08 .94 -0.18 -0.08 .94 
Note.  Means and statistical tests are adjusted for sex. a. Negative scores indicate that adolescents with cannabis dependence showed lower IQ/greater IQ 
decline than non-dependent adolescents. For example, results for the full sample show that IQ decline for adolescents with cannabis dependence was 1.55 
points greater than IQ decline for adolescents without cannabis dependence. b. IQ change was represented as a change score (age 18 IQ – age 12 IQ). We 
focused on IQ decline from age 12 to 18 because the age 12 and age 18 pro-rated IQ scores were based on the same two subtests (Information and Matrix 
Reasoning) whereas the age 5 pro-rated IQ scores were based on different subtests (Vocabulary and Block Design). Results are shown with and without 
adjustment for age 5 IQ. Statistically significant differences are shown in bold.  
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Supplemental Table 4.  Mean Information subtest scores at ages 12 and 18 and average within-person subtest score change from age 12 to 18 as a function 
of cannabis dependence at age 18. 
         
Full sample 
Non-Dependent 
Adolescents 
(N=1905) 
Cannabis 
Dependent 
Adolescents 
(N=84) 
Difference 
Between Non-
Dependent and 
Cannabis 
Dependent 
Adolescentsa t p 
Difference Between 
Non-Dependent and 
Cannabis Dependent 
Adolescents After 
Controlling for  
Age 5 IQa t p 
Age 12 Information Subtest 10.10 9.01 -1.09 -2.91 .004 -0.54 -1.70 .09 
Age 18  Information Subtest 10.10 8.55 -1.55 -5.58 <.001 -1.04 -4.11 <.001 
Change in Subtest Scoreb  0.00 -0.46 -0.46 -1.49 .14 -0.49 -1.64 .10 
         
Discordant Twins 
Non-Dependent 
Twins 
(N=57) 
Cannabis 
Dependent 
Co-Twin 
(N=57) 
Difference 
Between 
Discordant Twin 
Pairsa t p 
Difference Between 
Discordant Twin 
Pairs After 
Controlling for  
Age 5 IQa t p 
Age 12 Information Subtest 8.99 8.94 -0.05 -0.14 .89 -0.11 -0.31 .76 
Age 18  Information Subtest 9.12 8.77 -0.35 -1.21 .23 -0.40 -1.35 .18 
Change in Subtest Scoreb 0.13 -0.17 -0.30 -0.88 .38 -0.29 -0.82 .41 
Note. Means and statistical tests are adjusted for sex. a. Negative scores indicate that adolescents with cannabis dependence showed lower IQ/greater IQ 
decline than non-dependent adolescents. b. Change in the Information subtest score was represented as a change score (age 18 Information – age 12 
Information). We focused on subtest decline from age 12 to 18 because the age 12 and age 18 IQ tests were based on the same two subtests (Information 
and Matrix Reasoning) whereas the age 5 IQ test was based on different subtests (Vocabulary and Block Design). Results are shown with and without 
adjustment for age 5 IQ. Statistically significant differences are shown in bold. 
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Supplemental Table 5. Mean Matrix Reasoning subtest scores at ages 12 and 18 and average within-person subtest score change from age 12 to 18 as a 
function of cannabis dependence at age 18. 
         
Full sample 
Non-
Dependent 
Adolescents 
(N=1905) 
Cannabis 
Dependent 
Adolescents 
(N=84) 
Difference 
Between Non-
Dependent and 
Cannabis 
Dependent 
Adolescentsa t p 
Difference 
Between Non-
Dependent and 
Cannabis 
Dependent 
Adolescents 
After 
Controlling for 
Age 5 IQa t p 
Age 12 Matrix Reasoning Subtest 10.10 9.29 -0.81 -2.44 .015 -0.39 -1.25 .21 
Age 18 Matrix Reasoning Subtest 10.07 9.25 -0.82 -2.48 .014 -0.51 -1.60 .11 
Change in Subtest Scoreb -0.03 -0.04 -0.01 -0.04 .97 -0.11 -0.34 .73 
         
Discordant Twins 
Non-
Dependent 
Twins 
(N=57) 
Cannabis 
Dependent Co-
Twin 
(N=57) 
Difference 
Between 
Discordant Twin 
Pairsa t p 
Difference 
Between 
Discordant Twin 
Pairs After 
Controlling for 
Age 5 IQa t p 
Age 12  Matrix Reasoning Subtest 9.45 9.02 -0.43 -0.96 .34 -0.47 -1.04 .30 
Age 18 Matrix Reasoning Subtest 9.00 8.90 -0.10 -0.20 .84 -0.16 -0.31 .76 
Change in Subtest Scoreb -0.45 -0.12 0.33 0.58 .56 0.32 0.55 .58 
Note. Means and statistical tests are adjusted for sex. a. Negative scores indicate that adolescents with cannabis dependence showed lower IQ/greater IQ 
decline than non-dependent adolescents. b. Change in the Matrix Reasoning subtest score was represented as a change score (age 18 Information – age 12 
Information). We focused on subtest decline from age 12 to 18 because the age 12 and age 18 IQ tests were based on the same two subtests (Information 
and Matrix Reasoning) whereas the age 5 IQ test was based on different subtests (Vocabulary and Block Design). Results are shown with and without 
adjustment for age 5 IQ. Statistically significant differences are shown in bold. 
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Supplemental Table 6. Mean pro-rated IQ scores at ages 5, 12, and 18 and IQ subtest scores at ages 12 and 18. Means are shown for adolescents who 
did not use cannabis in the past year at age 18 and adolescents who used cannabis on a weekly or greater basis at age 18. Means for IQ change 
represent average within-individual IQ change. 
         
 Pro-Rated Full Scale IQ 
Full sample 
Non-User 
(N=1242) 
Weekly+ User 
(N=132) 
Difference 
Between Non-
Users and 
Weekly+ Usersa t p 
Difference 
Between Non-
Users and 
Weekly+ Users 
After Controlling 
for Age 5 IQa t p 
Age 5 IQ 100.17 95.94 -4.23 -2.91 .004 - - - 
Age 12 IQ 100.91 94.31 -6.60 -5.21 <.001 -4.40 -4.08 <.001 
Age 18 IQ 101.11 92.99 -8.12 -6.53 <.001 -6.13 -5.57 <.001 
IQ Change From Age 12-18b 0.20 -1.32 -1.52 -1.43 .15 -1.73 -1.64 .10 
         
Discordant Twins 
Non-User 
(N=23) 
Weekly+ User 
(N=23) 
Difference 
Between 
Discordant Twin 
Pairsa t p 
Difference 
Between 
Discordant Twin 
Pairs After 
Controlling for 
Age 5 IQa t p 
Age 5 IQ 97.46 98.27 0.81 0.18 .86 - - - 
Age 12 IQ 94.49 101.15 6.66 1.83 .07 6.39 1.91 .06 
Age 18 IQ 94.74 98.13 3.39 0.82 .42 3.02 0.83 .41 
IQ Change From Age 12-18b 0.25 -3.02 -3.27 -0.95 .35 -3.37 -0.98 .33 
         
 Information Subtest 
Full Sample 
Non-User 
(N=1242) 
Weekly+ User 
(N=132) 
Difference 
Between Non-
Users and 
Weekly+ Usersa t p 
Difference 
Between Non-
Users and 
Weekly+ Users t p 
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After Controlling 
for Age 5 IQa 
Age 12 IQ 10.16 8.76 -1.40 -5.49 <.001 -0.96 -4.34 <.001 
Age 18 IQ 10.24 8.44 -1.80 -7.79 <.001 -1.40 -6.72 <.001 
IQ Change From Age 12-18b 0.08 -0.32 -0.40 -1.95 .05 -0.44 -2.09 .037 
         
Discordant Twins 
Non-User 
(N=23) 
Weekly+ User 
(N=23) 
Difference 
Between 
Discordant Twin 
Pairsa t p 
Difference 
Between 
Discordant Twin 
Pairs After 
Controlling for 
Age 5 IQa t p 
Age 12 IQ 8.76 10.10 1.34 1.91 .06 1.31 1.90 .06 
Age 18 IQ 9.15 10.24 1.09 1.48 .15 1.05 1.47 .15 
IQ Change From Age 12-18b 0.39 0.14 -0.25 -0.38 .70 -0.25 -0.38 .70 
     
 Matrix Reasoning Subtest 
Full Sample 
Non-User 
(N=1242) 
Weekly+ User 
(N=132) 
Difference 
Between Non-
Users and 
Weekly+ Usersa t p 
Difference 
Between Non-
Users and 
Weekly+ Users 
After Controlling 
for Age 5 IQa t p 
Age 12 IQ 10.15 9.33 -0.82 -3.32 <.001 -0.50 -2.23 .026 
Age 18 IQ 10.12 9.33 -0.79 -2.75 .006 -0.55 -2.00 .046 
IQ Change From Age 12-18b -0.03 0.00 0.03 0.11 .91 -0.05 -0.17 .87 
         
Discordant Twins 
Non-User 
(N=23) 
Weekly+ User 
(N=23) 
Difference 
Between 
Discordant Twin 
Pairsa t p 
Difference 
Between 
Discordant Twin 
Pairs After 
Controlling for 
Age 5 IQa t p 
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Age 12 IQ 9.37 10.34 0.97 1.28 .21 0.91 1.33 .19 
Age 18 IQ 9.10 9.06 -0.04 -0.04 .97 -0.13 -0.15 .88 
IQ Change From Age 12-18b -0.27 -1.28 -1.01 -1.16 .25 -1.04 -1.20 .24 
Note. Means and statistical tests are adjusted for sex. a. Negative scores indicate that adolescents who used cannabis at least weekly showed lower 
IQ/greater IQ decline than adolescents who did not use cannabis in the past year. b. IQ change was represented as a change score (age 18 IQ – age 12 
IQ). We focused on IQ decline from age 12 to 18 because the age 12 and age 18 pro-rated IQ scores were based on the same two subtests (Information 
and Matrix Reasoning) whereas the age 5 pro-rated IQ scores were based on different subtests (Vocabulary and Block Design). Results are shown with 
and without adjustment for age 5 IQ. Statistically significant differences are shown in bold. 
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Supplemental Table 7. Mean executive function scores for adolescents who did not use cannabis in the past year at age 18 and adolescents who used 
cannabis weekly or more in the past year at age 18. 
                 
 Full Sample Discordant Twins 
 
Before Controlling for  
Age 12 IQ 
After Controlling for 
Age 12 IQ 
Before Controlling for  
Age 12 IQ 
After Controlling for 
Age 12 IQ 
Executive Functions 
Non-
User 
(N= 
1,242) 
Weekly 
User 
(N= 
132) t p 
Non-
User 
(N= 
1,242) 
Weekly 
User 
(N= 
132) t p 
Non-
User 
(N=
23) 
Weekly 
User 
(N=23) t p 
Non-
User 
(N=
23) 
Weekly 
User 
(N=23) t p 
RVP A Prime 0.06 -0.28 -3.85 <.001 0.04 -0.11 -1.74 .08 0.02 0.12 0.37 .71 0.08 0.06 -0.08 .94 
                 
RVP Total False 
Alarmsa -0.03 0.03 0.71 .48 -0.02 -0.07 -0.55 .58 -0.05 -0.31 -0.98 .34 -0.05 -0.30 -0.93 .36 
                 
SWM Total Errorsa -0.07 0.29 3.91 <.001 -0.05 0.14 2.33 .020 0.02 -0.12 -0.79 .44 -0.05 -0.05 -0.04 .97 
                 
SWM Strategya -0.05 0.28 3.98 <.001 -0.03 0.14 2.19 
 
.029 0.14 0.08 -0.24 .81 0.04 0.18 0.55 .59 
                 
Spatial Span Forward 0.06 -0.48 -5.95 <.001 0.04 -0.33 -4.43 <.001 -0.10 -0.07 0.14 .89 0.00 -0.16 -0.75 .46 
                 
Spatial Span Reversed 0.07 -0.42 -5.49 <.00` 0.05 -0.27 -4.01 <.001 0.14 -0.29 -1.80 .09 0.14 -0.29 -1.91 .07 
Note. Means and statistical tests are adjusted for sex. Non-user=did not use cannabis in the past year at age 18. Weekly User=used cannabis weekly or more 
in the past year at age 18. RVP=Rapid Visual Processing. SWM=Spatial Working Memory. For the full sample, Ns ranged from 1238-1242 for the non-
user group and 130-132 for the user group, as a few people from each group did not complete all executive function tests. For discordant twins, N=23 twin 
pairs. a. Higher scores are worse. Statistically significant differences are shown in bold. 
